CTT Pharmaceutical Holdings, Inc. CTTH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.80K | 76.60K | 36.90K | 32.90K | 32.90K |
| Depreciation & Amortization | 1.70K | 1.70K | 6.40K | 1.60K | 1.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.50K | 78.30K | 43.40K | 34.50K | 34.50K |
| Operating Income | -9.50K | -78.30K | -43.40K | -34.50K | -34.50K |
| Income Before Tax | -15.20K | -84.70K | -50.30K | -45.10K | -45.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.20K | -84.70K | -50.30K | -45.10K | -45.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.20K | -84.70K | -50.30K | -45.10K | -45.10K |
| EBIT | -9.50K | -78.30K | -43.40K | -34.50K | -34.50K |
| EBITDA | -7.80K | -76.60K | -41.70K | -32.90K | -32.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 59.05M | 59.05M | 58.26M | 57.27M | 57.27M |
| Average Diluted Shares Outstanding | 59.05M | 59.05M | 58.26M | 57.27M | 57.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |